2026-11-02 · post
The Small Link in the Bacterial Shield: Skinjo Interviews Jack
This post relates to another entry. Read it here.
Morning light crosses the notebook between Skinjo and Jack. His camera rests beside it in the temporary Petra field room. Skinjo turns the blank page toward him.
“What keeps a bacterium’s outer wall together?” Skinjo asks. “And where does a sugar hardly anyone has heard of fit into that picture?”
“First, a distinction,” Jack says. “The cell wall has a mesh that provides support. In Gram-negative bacteria, there’s also an outer membrane beyond that mesh. That’s the layer we’re looking at.”
He draws two rows of short strokes, then adds a few wavering branches above them.
“Not to scale,” he says. “Or likely to win you over as a drawing.”
“It gives us somewhere to look,” Skinjo says. “Keep going.”
“The outer-facing surface contains molecules called lipopolysaccharides—LPS for short. Each has a fatty anchor, lipid A, sitting in the membrane, with sugars extending outward.”
Jack labels the anchor, then a small connecting shape above it: Kdo. Beyond that he sketches a cluster of sugars and a longer chain.
“Kdo sits here, linking lipid A to the core sugar region. Many bacteria also have a longer, repeating sugar chain beyond the core. Kdo’s full name is 3-deoxy-D-manno-oct-2-ulosonic acid. It’s an eight-carbon sugar acid.”
Skinjo leans toward the little shape. “So the smallest mark on your page is doing a fairly important job.”
“Yes. But it isn’t glue holding the whole bacterium together. It’s a connecting part within this protective surface. The surrounding molecules and their interactions matter too.”
“And that makes it a weak point?”
“A possible one. To build that surface properly, many Gram-negative bacteria need to make Kdo and attach it in the right place. Chemists study the enzymes that do those jobs. Interrupt an essential assembly step, and you may weaken the barrier or stop the bacterium growing.”
“May,” Skinjo repeats.
“An important word. Finding a vulnerable step isn’t the same as having a medicine. A compound still has to reach its target, work safely, and work against the bacteria you want to treat.”
Skinjo draws a loose frame around the diagram, leaving the tiny Kdo label unobscured.
“The part most people wouldn’t notice,” she says.
“Until they ask how the pieces join,” Jack replies.
Skinjo
Jack